Figure 3 from Opioid receptors: distinct roles in mood disorders | Semantic Scholar
Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY | eNeuro
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction: Trends in Neurosciences
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Pathways and Receptors – Opioid Peptides
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
PDF) Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink